Fundraising FoxHuman Longevity
San Diego, US · Delaware corporation · 2 known investors
Find your way into Human Longevity
Sign up to see every warm intro you have to Human Longevity
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Human Longevity team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
DK
David KarowExecutive
JH
James HuExecutiveJames Hu is an executive at Human Longevity with background in life science research and biotechnology tools, including business development, licensing, sales, and marketing roles.
Board
WH
Wei-Wu HeBoard director
JH
James HuangBoard director
HS
Helmut SchuehslerBoard director
Investors · 2
Silver Lake Partnerslisted by Silver Lake PartnersMenlo Park
How we know: Silver Lake Partners's portfolio page · Not right? Tell us
GE VenturesreportedCincinnati
How we know: offering press articles · open dataset · 5k.vc investor directory · Not right? Tell us
Funding
SEC filings, press & company announcements$59M disclosed across 3 of 4 rounds · 2019–2024
- Undisclosed amountSeries BAug 2024Source ↗
▶$32MraisedAug 2024 · 18 investors · BiotechnologyRule 506(b)
▶$32MraisedAug 2024 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Wei-Wu HeDirector
- James HuangDirector
- Helmut SchuehslerDirector
- David KarowExecutive Officer, Director
- James HuExecutive Officer, Director
- Offering amount
- $32M
- Amount sold
- $32M
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.9MraisedOct 2022 · 11 investors · BiotechnologyRule 506(b)
▶$6.9MraisedOct 2022 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Wei-Wu HeDirector
- David KarowExecutive Officer, Director
- James HuExecutive Officer, Director
- Offering amount
- $11.7M
- Amount sold
- $6.9M
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20.1MraisedJul 2019 · 1 investors · BiotechnologyRule 506(b)
▶$20.1MraisedJul 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David KarowExecutive Officer, Director
- Wei-Wu HeDirector
- James HuDirector
- Offering amount
- $30M
- Amount sold
- $20.1M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Human Longevity's investors?
- Human Longevity's investors include Silver Lake Partners, GE Ventures.
- How much funding has Human Longevity raised?
- Human Longevity has disclosed $59M raised across 3 of its 4 known rounds.
- Where is Human Longevity headquartered?
- Human Longevity is headquartered in San Diego, US.